D. Cutler

发表

Linear systems analysis in pharmacokinetics

D. Cutler, 1978, Journal of Pharmacokinetics and Biopharmaceutics.

The potential role of lysosomes in tissue distribution of weak bases

D. Cutler, A. Macintyre, Anna C. Macintyre, 1988, Biopharmaceutics & drug disposition.

Uptake of chloroquine by human erythrocytes.

D. Cutler, V. Ferrari, 1990, Biochemical pharmacology.

Pure drug nanoparticles in tablets: what are the dissolution limitations?

J. Raper, D. Cutler, J. Yun, 2010 .

In vitro binding of chloroquine to rat muscle preparations.

D. Cutler, A. Macintyre, 1986, Journal of pharmaceutical sciences.

Role of lysosomes in hepatic accumulation of chloroquine.

D. Cutler, A. Macintyre, 1988, Journal of pharmaceutical sciences.

Bioavailability of hydroxychloroquine tablets in healthy volunteers.

R. Day, D. Cutler, S. Tett, 1989, British journal of clinical pharmacology.

Kinetics of metabolism and degradation of mometasone furoate in rat biological fluids and tissues

N. Davies, D. Cutler, X. Teng, 2003, The Journal of pharmacy and pharmacology.

Simulation of gastrointestinal drug absorption I. Longitudinal transport in the small intestine

D. Cutler, S. J. Firmer, 1988 .

Metabolism Kinetics of Beclomethasone Propionate Esters in Human Lung Homogenates

D. Cutler, K. Brown, J. P. Seale, 2000, Pharmaceutical Research.

Apparent dose-dependence of chloroquine pharmacokinetics due to limited assay sensitivity and short sampling times

D. Cutler, S. Tett, 2004, European Journal of Clinical Pharmacology.

Concentration-effect relationship of hydroxychloroquine in rheumatoid arthritis--a cross sectional study.

R. Day, D. Cutler, S. Tett, 1993, The Journal of rheumatology.

Disposition of the enantiomers of hydroxychloroquine in patients with rheumatoid arthritis following multiple doses of the racemate.

R. Day, D. Cutler, S. Tett, 1993, British journal of clinical pharmacology.

Antimalarials in rheumatic diseases.

R. Day, D. Cutler, S. Tett, 1990, Bailliere's clinical rheumatology.

A dose-ranging study of the pharmacokinetics of hydroxy-chloroquine following intravenous administration to healthy volunteers.

R. Day, D. Cutler, S. Tett, 1988, British journal of clinical pharmacology.

Pharmacokinetics and cellular uptake of 4-aminoquinoline antimalarials.

D. Cutler, A. Macintyre, S. Tett, 1988, Agents and actions. Supplements.

Sensitive stereospecific assay of warfarin in plasma: reversed-phase high-performance liquid chromatographic separation using diastereoisomeric esters of (-)-(1S,2R,4R)-endo-1,4,5,6,7,7-hexachlorobicyclo[2.2.1]-hept-5- ene-2-carboxylic acid.

D. Cutler, G. Holder, C. Duke, 1992, Journal of chromatography.

Electrophysiological effects of opioid receptor activation on Syrian hamster suprachiasmatic nucleus neurones in vitro

D. Cutler, R. Mason, M. Mundey, 1999, Brain Research Bulletin.

Mometasone furoate degradation and metabolism in human biological fluids and tissues

N. Davies, D. Cutler, Neil Davies, 2003, Biopharmaceutics & drug disposition.

Concentration-effect relationship of hydroxychloroquine in patients with rheumatoid arthritis--a prospective, dose ranging study.

R. Day, D. Cutler, S. Tett, 2000, The Journal of rheumatology.

Bioavailability of hydroxychloroquine tablets in patients with rheumatoid arthritis.

R. Day, D. Cutler, S. Tett, 1994, British journal of rheumatology.

Pharmacokinetics and pharmacodynamics of hydroxychloroquine enantiomers in patients with rheumatoid arthritis receiving multiple doses of racemate.

R. Day, D. Cutler, S. Tett, 1994, Chirality.

Electrophysiological actions of orexins on rat suprachiasmatic neurons in vitro

D. Cutler, A. Coogan, H. Piggins, 2008, Neuroscience Letters.

Kinetics of chloroquine uptake into isolated rat hepatocytes.

D. Cutler, A. Macintyre, 1993, Journal of pharmaceutical sciences.

Gentamicin clearance during continuous arteriovenous hemodiafiltration

D. Cutler, D. Ernest, 1992, Critical care medicine.

Analysis of warfarin enantiomers: Chromatographic separation of six stereoisomeric esters prepared from (−)‐(1S,2R,4R)‐endo‐1,4,5,6,7,7‐hexachlorobicyclo[2.2.1]hept‐5‐ene‐2‐ carboxylic acid

T. Hambley, D. Cutler, G. Holder, 1994 .

High-performance liquid chromatographic analysis of mometasone furoate and its degradation products: application to in vitro degradation studies.

N. Davies, D. Cutler, K. Brown, 2001, Journal of pharmaceutical and biomedical analysis.

Focused-ion-beam Milling: A Novel Approach to Probing the Interior of Particles Used for Inhalation Aerosols

D. Cutler, J. Cairney, J. Yun, 2007, Pharmaceutical Research.

What is a Suitable Dissolution Method for Drug Nanoparticles?

J. Raper, D. Cutler, J. Yun, 2008, Pharmaceutical Research.

Multiple pharmacokinetic parameter prediction for a series of cephalosporins.

Snezana Agatonovic-Kustrin, J. V. Turner, D. Cutler, 2003, Journal of pharmaceutical sciences.

Pharmacokinetic parameter prediction from drug structure using artificial neural networks.

J. V. Turner, D. Cutler, Joseph V Turner, 2004, International journal of pharmaceutics.

Theory of the mean absorption time, an adjunct to conventional bioavailability studies

D. Cutler, D. Cutler, 1978, The Journal of pharmacy and pharmacology.

Interpretation of chloroquine pharmacokinetic data

R. Day, D. Cutler, S. Tett, 1993, European Journal of Clinical Pharmacology.

Plasma protein binding of the enantiomers of hydroxychloroquine and metabolites

D. Cutler, S. Tett, A. McLachlan, 1993, European Journal of Clinical Pharmacology.

Bioavailability of hydroxychloroquine tablets assessed with deconvolution techniques.

R. Day, D. Cutler, S. Tett, 1992, Journal of pharmaceutical sciences.

Disposition and absorption of hydroxychloroquine enantiomers following a single dose of the racemate.

R. Day, D. Cutler, S. Tett, 1994, Chirality.

High-performance liquid chromatographic separation of the enantiomers of hydroxychloroquine and its major metabolites in biological fluids using an alpha 1-acid glycoprotein stationary phase.

D. Cutler, S. Tett, A. McLachlan, 1991, Journal of chromatography.

High-performance liquid chromatographic assay for hydroxychloroquine and metabolites in blood and plasma, using a stationary phase of poly(styrene divinylbenzene) and a mobile phase at pH 11, with fluorimetric detection.

D. Cutler, S. Tett, K. Brown, 1985, Journal of chromatography.

Simulation of kinetic data on the influx and efflux of chloroquine by erythrocytes infected with Plasmodium falciparum. Evidence for a drug-importer in chloroquine-sensitive strains.

D. Cutler, V. Ferrari, Victor Ferrari, 1991, Biochemical pharmacology.

Temperature dependence of the acid dissociation constants of chloroquine.

D. Cutler, V. Ferrari, 1987, Journal of pharmaceutical sciences.

Vasoactive intestinal polypeptide (VIP) phase‐shifts the rat suprachiasmatic nucleus clock in vitro

D. Cutler, H. Piggins, H D Piggins, 2001, The European journal of neuroscience.

On the definition of the compartment concept in pharmacokinetics.

D. Cutler, D J Cutler, 1978, Journal of theoretical biology.

A kinetic study of the role of band 3 anion transport protein in the transport of salicylic acid and other hydroxybenzoic acids across the human erythrocyte membrane.

D. Cutler, T. Minami, 1992, Journal of pharmaceutical sciences.

The hypothalamus and the regulation of energy homeostasis: lifting the lid on a black box

D. Cutler, J. Harrold, G. Williams, 2000, Proceedings of the Nutrition Society.

Restoration of pyrethroid susceptibility in a highly resistant Aedes aegypti population

D. Cutler, G. Vazquez-Prokopec, L. Morran, 2018, Biology Letters.

A phase II study of oraxol in the treatment of unresectable cutaneous angiosarcoma.

Michael R. Wagner, T. Chen, D. Cutler, 2020 .

Differential distribution of orexin-A and orexin-B immunoreactivity in the rat brain and spinal cord☆

Shelagh Wilson, R. Morris, D. Cutler, 1999, Peptides.

Orexin-A immunoreactive neurons in the rat hypothalamus do not contain neuronal nitric oxide synthase (nNOS)

R. Morris, D. Cutler, R. Leslie, 2001, Peptides.

Hydroxychloroquine relative bioavailability: within subject reproducibility.

R. Day, D. Cutler, S. Tett, 1996, British journal of clinical pharmacology.

Ionophoretically applied substance P activates hamster suprachiasmatic nucleus neurons

D. Cutler, H. Piggins, B. Rusak, 1995, Brain Research Bulletin.

Aberrant Gating of Photic Input to the Suprachiasmatic Circadian Pacemaker of Mice Lacking the VPAC2 Receptor

D. Cutler, A. Coogan, H. Piggins, 2004, Journal of Neuroscience.

The mouse VPAC2 receptor confers suprachiasmatic nuclei cellular rhythmicity and responsiveness to vasoactive intestinal polypeptide in vitro

Sanbing Shen, Anthony J Harmar, D. Cutler, 2003, The European journal of neuroscience.

Pharmacokinetics of dexamethasone and its relationship to dexamethasone suppression test outcome in depressed patients and healthy control subjects

D. Cutler, G. Johnson, I. Caterson, 1997, Biological Psychiatry.

Distribution of substance P and neurokinin‐1 receptor immunoreactivity in the suprachiasmatic nuclei and intergeniculate leaflet of hamster, mouse, and rat

D. Cutler, A. Coogan, H. Piggins, 2001, The Journal of comparative neurology.

Definition of mean residence times in pharmacokinetics.

D. Cutler, 1987, Biopharmaceutics & drug disposition.

A comment regarding mean residence times in non-linear systems.

D. Cutler, 1989, Biopharmaceutics & drug disposition.

Level B and C in vivo/in vitro correlations: statistical considerations

D. Cutler, J. Aiache, E. Beyssac, 1997 .

Dissolution kinetic behavior of drug nanoparticles and their conformity to the diffusion model.

J. Raper, D. Cutler, J. Yun, 2008, Langmuir : the ACS journal of surfaces and colloids.

Neurochemical Aspects of the Entrainment of the Mammalian Suprachiasmatic Circadian Pacemaker

D. Cutler, A. Coogan, H. Piggins, 2002 .

Numerical deconvolution by least squares: Use of prescribed input functions

D. Cutler, David J. Cutler, 1978, Journal of Pharmacokinetics and Biopharmaceutics.

Selective descriptor pruning for QSAR/QSPR studies using artificial neural networks

Ian Spence, David J. Cutler, Desmond J. Maddalena, 2003, J. Comput. Chem..

Kinetics and thermodynamics of chloroquine and hydroxychloroquine transport across the human erythrocyte membrane.

D. Cutler, V. Ferrari, 1991, Biochemical pharmacology.

A linear recirculation model for drug disposition

D. Cutler, 1979, Journal of Pharmacokinetics and Biopharmaceutics.

On the mechanism of transport of salicylate and p‐hydroxybenzoic acid across human red cell membranes

D. Cutler, D. Cutler, M. Joy, 1987, The Journal of pharmacy and pharmacology.

Insights from pharmacokinetic and pharmacodynamic studies of hydroxychloroquine.

R. Day, D. Cutler, S. Tett, 1993, Agents and actions. Supplements.

Phase I Maximal Use Pharmacokinetic Study of Tirbanibulin Ointment 1% in Subjects with Actinic Keratosis

D. Cutler, J. Overcash, J. Zhi, 2020 .